Nasal Studies

INVESTIOGATIONAL BIOLOGIC TREATMENT FOR NASAL POLYPS

Age 19+

WAYPOINT NASAL POLYP

We are doing this study to learn more about the effect and safety of Tezepelumab when given to patients with severe chronic rhinosinusitis with nasal polyposis (NP) and also to better understand the studied disease and associated health problems.

INVESTIOGATIONAL DEVICE FOR TREATMENT OF CHRONIC RHINITIS

Age 18+

NEURENT MEDICAL

The objective of this study is to evaluate the safety and efficacy of the NEUROMARK™ system, an investigational medical device manufactured by Neurent Medical. The system is designed to address symptoms related to Chronic Rhinitis (reoccurring stuffy and/or runny nose). The focus of this study is to evaluate if the procedure is safe for humans and if the device can improve your nasal symptoms. The delivery of energy is aimed to interrupt nerves that affect mucus (snot) production.

BIOLOGIC TREATMENT FOR ALLERGIC FUNGAL RHINOSINUSITIS

Age 12+

SANOFI AFRS

The purpose of the study is to evaluate how safe and effective the investigational study drug, dupilumab, is in reducing signs and symptoms in patients with AFRS.

Become a Participant in our Nasal Polyps Studies

If you’re interested in participating in a clinical research study at the Clinical Research Center of Alabama, call 205.209.4100 to speak with an experienced coordinator or fill out the contact form below.